Explore 3 Stock Ideas & Industry Insights Download Free Report

Acutus Medical Inc

Company price
0.0001 USD 0.00(0%)
Last update at 2026-11-19T21:00:00Z
VOLUME
10000
Market Cap
0.00M

Momentum Score

…

Acutus Medical, Inc. designs, manufactures, and markets various tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. Its product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. Acutus Medical, Inc. was incorporated in 2011 and is headquartered in Carlsbad, California.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.00
Low
0.00
High
52 Week Price Range
-
Low
0.00
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Acutus Medical develops high-resolution cardiac mapping systems and catheters to diagnose and treat complex arrhythmias including atrial fibrillation. Long-term growth may be driven by rising atrial arrhythmia prevalence, wider adoption of mapping-guided ablation, and international expansion. The company may appeal to investors seeking exposure to niche electrophysiology technology that appears positioned to improve procedural efficiency and outcomes.
Key risks include financial and listing uncertainty with limited public-market liquidity, intense competition from larger electrophysiology device makers, and regulatory and reimbursement exposure that could constrain adoption.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.00
Dividend Yield
-
Revenue TTM
20.16M
Revenue Per Share
0.68
Gross Profit TTM
1.01M
Debt / Equity
-3.09
ROE
-49.22%
Net Debt
21.75M
ROCE
7.54%
Diluted EPS TTM
-0.15

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Income before tax -4.54M -11.86M -39.53M -117.68M -101.96M
Net income -9.55M -81.66M -39.62M -123.36M -101.98M
Selling general administrative 10.44M 35.73M 47.65M 63.52M 50.36M
Gross profit 1.01M -3.14M -15.55M -15.66M -7.42M
Reconciled depreciation 1.03M 5.79M 7.13M 6.89M 3.90M
Ebit 1.22M -6.20M -27.34M -112.12M -91.33M
Ebitda 2.25M -5.33M -83.36M -108.86M -86.90M
Depreciation and amortization 1.03M 0.87M -56.02M 3.26M 4.44M
Non operating income net other - - - - -5.17M
Operating income -0.06M -14.36M -27.34M -112.12M -91.33M
Other operating expenses 20.21M 21.52M 107.72M 133.13M 99.70M
Interest expense 5.76M 5.66M 5.15M 5.68M 5.51M
Tax provision 0.00M 0.16M 0.08M 0.00M 0.02M
Interest income 0.76M 2.80M 0.87M 0.12M 0.44M
Net interest income -5.00M -2.65M -4.28M -5.56M -5.07M
Income tax expense 0.01M 0.06M 0.08M 5.68M 0.02M
Total revenue 20.16M 7.16M 16.36M 17.26M 8.46M
Total operating expenses 1.07M 11.22M 75.81M 100.21M 83.81M
Cost of revenue 19.14M 10.30M 31.91M 32.92M 15.89M
Total other income expense net -4.48M 2.50M -12.20M -5.56M -10.62M
Net income from continuing ops -4.54M -32.79M -39.62M -117.68M -101.98M
Net income applicable to common shares - - -39.62M -117.68M -101.98M
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Total assets 28.65M 53.96M 133.44M 169.79M 192.53M
Intangible assets - - 1.58M 5.01M 5.65M
Other current assets 1.89M 1.19M 7.24M 5.48M 5.20M
Total liab 40.24M 54.84M 58.42M 64.07M 65.95M
Total stockholder equity -11.59M -0.88M 75.02M 105.73M 126.58M
Other current liab 3.20M 13.60M 14.51M 10.20M 12.41M
Common stock 0.03M 0.03M 0.03M 0.03M 0.03M
Capital stock 0.03M 0.03M 0.03M 0.03M 0.03M
Retained earnings -609.52M -599.98M -518.31M -478.70M -361.01M
Other liab - - 0.01M 0.55M 3.90M
Good will - - 0.00M 12.03M 12.03M
Other assets - 0.00M 0.90M 1.15M 0.72M
Cash 14.02M 26.20M 25.58M 24.07M 25.23M
Total current liabilities 12.44M 18.94M 19.87M 18.51M 21.91M
Current deferred revenue - - 0.33M 0.40M 0.30M
Net debt 21.75M 12.28M 13.27M 21.33M 15.84M
Short term debt 7.96M 2.58M 0.32M 0.40M 0.93M
Short long term debt 7.00M 1.86M - - -
Short long term debt total 35.76M 38.48M 38.86M 45.40M 41.08M
Other stockholder equity 598.67M 599.93M 594.17M 584.61M 294.75M
Property plant equipment - - 13.09M 18.19M 14.03M
Total current assets 25.58M 46.25M 117.87M 126.29M 151.39M
Long term investments - - 0.00M 7.12M 8.73M
Net tangible assets - - 73.44M 88.69M 108.90M
Short term investments 0.00M 3.23M 44.86M 76.70M 105.84M
Net receivables 7.88M 11.35M 21.09M 3.63M 2.16M
Long term debt 25.56M 32.65M 34.43M 40.41M 39.01M
Inventory 1.79M 4.28M 13.33M 16.41M 12.96M
Accounts payable 1.28M 2.76M 4.72M 7.52M 8.27M
Accumulated other comprehensive income -0.77M -0.87M -0.87M -0.22M 0.28M
Common stock total equity - - - - 0.03M
Retained earnings total equity - - - - -361.01M
Non currrent assets other 0.09M 3.69M 0.90M 1.15M 0.72M
Non current assets total 3.07M 7.71M 15.57M 43.50M 41.15M
Capital lease obligations 3.19M 3.96M 4.42M 4.99M 2.07M
Long term debt total - - - - 39.01M
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Investments 22.15M 59.55M 104.75M 19.07M -52.60M
Change to liabilities - - -2.85M -0.87M 2.28M
Total cashflows from investing activities 22.15M 58.55M 104.75M 19.07M -63.82M
Net borrowings -2.62M 0.00M -9.72M -9.72M -9.72M
Total cash from financing activities -2.89M -2.66M -12.12M 79.57M 164.43M
Change to operating activities - - 3.32M 2.43M -2.59M
Net income -4.54M -39.62M -39.62M -117.68M -101.98M
Change in cash -12.18M -5.15M 7.13M -1.16M 15.78M
Begin period cash flow 26.20M 31.35M 24.22M 25.38M 9.60M
End period cash flow 14.02M 26.20M 31.35M 24.22M 25.38M
Total cash from operating activities -31.66M -63.12M -85.03M -99.68M -85.17M
Issuance of capital stock - - 0.00M 82.66M 166.29M
Depreciation 1.03M 0.87M 7.13M 6.89M 3.90M
Other cashflows from investing activities 0.23M -1.21M - - -
Change to inventory 2.49M -2.48M 3.08M -3.87M -3.89M
Change to account receivables -4.05M -1.07M -0.45M -1.47M -1.90M
Sale purchase of stock - -0.11M -0.11M - 166.93M
Other cashflows from financing activities -0.27M -2.69M 33.54M -3.09M -1.85M
Change to netincome - - -51.79M 13.49M 18.24M
Capital expenditures 0.11M 0.22M 3.98M 9.97M 11.22M
Change receivables - - - - -1.90M
Cash flows other operating - - - - 1.41M
Cash and cash equivalents changes - - - - 15.44M
Change in working capital -4.01M 0.92M -1.61M -3.79M -6.10M
Stock based compensation 0.46M 3.03M 9.39M 13.75M 12.10M
Other non cash items -24.60M -28.32M -60.33M -0.16M 0.86M
Free cash flow -31.77M -63.34M -89.02M -109.66M -96.39M

Peer Comparison*

Sector: Healthcare Industry: Medical Devices

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
AFIB
Acutus Medical Inc
-
-%
0.00 - - 0.00 0.16 1.08 9.67
ABT
Abbott Laboratories
-0.20
0.19%
103.00 25.97 17.24 3.57 3.20 3.81 16.75
MDT
Medtronic PLC
-0.59
0.59%
100.02 26.60 15.87 3.35 2.08 3.90 14.12
SYK
Stryker Corporation
-
-%
310.00 29.23 16.86 4.18 4.51 4.63 17.16
SEMHF
Siemens Healthineers AG
-
-%
48.34 39.57 21.32 3.01 3.29 2.95 16.92

Profile*

Acutus Medical Inc

Acutus Medical, Inc. designs, manufactures, and markets various tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. Its product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. Acutus Medical, Inc. was incorporated in 2011 and is headquartered in Carlsbad, California.

2210 Faraday Avenue, Carlsbad, CA, United States, 92008

442 232 6080

85

Name Title Year Born
Mr. R. Scott Huennekens CPA, M.B.A. Exec. Chairman 1964
Mr. David Harrison Roman CEO, Pres & Director 1982
Mr. Vincent J. Burgess Consultant 1965
Mr. Takeo Mukai VP of Fin. & Accounting and Interim CFO NA
Dr. Graydon E. Beatty Chief Technology Officer 1957
Dr. Derrick Chou Ph.D. Chief Technology Officer NA
Mr. Tom Sohn Sr. VP, Gen. Counsel & Sec. 1975
Mr. Shibaji Shome Ph.D. VP of Marketing NA
Mr. Charlie Piscitello Sr. VP & Chief People Officer 1963
Mr. Gary W. Doherty Sr. VP of Fin. 1966

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…